相关实验视频
Updated: Jul 19, 2025

08:54
Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
1.1K
pH触发的动态侵蚀性小分子ambucil纳米产物介导强大的口服化疗
Xin Liu1, Zhexiang Wang1, Xiaodie Ren1
1Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, Hefei 230601, China.
Asian journal of pharmaceutical sciences
|August 16, 2023
概括
这项研究开发了用于口服化疗的pH触发的纳米产物. 这些动态侵蚀性小分子纳米产物改善药物递送和瘤抑制,提供了一个有前途的新治疗途径.
科学领域:
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
- 口服化疗是一种口服化疗.
背景情况:
- 口服化疗因生理障碍而面临生物可用性挑战.
- 小分子纳米产品提供了改善口服输送的潜力.
- 动态侵蚀系统对于受控的药物释放是可取的.
研究的目的:
- 开发pH触发的动态侵蚀性小分子纳米前药物用于口服化疗.
- 为了提高口服生物利用率和瘤特异性药物输送.
- 调查开发的纳米原药的治疗疗效和安全性.
主要方法:
- 合成纳米前药物通过氨酸和恒星形的整形之间的胺反应.
- 物理化学性质的表征,包括药物负载,尺寸转变和电荷.
- 评估体内性能,包括胃肠道吸收,血液循环稳定性,瘤积累和治疗效果.
主要成果:
- 开发了精确的纳米产物,具有高药物负载 (68.16%) 和电中性.
- 观察到动态尺寸从大到小的转变,以响应pH值的变化 (胃肠道到瘤).
- 获得显著增强的口服相对生物利用率 (358.72%) 和强大的瘤生长抑制与减少副作用.
结论:
- pH触发的动态侵蚀性纳米产物显示出口服化疗的巨大前景.
- 开发的系统有效地克服了改善药物输送的生理障碍.
- 这种方法为强大的口腔癌治疗提供了一个新的,在临床上可转化战略.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
199
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
199
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
243
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
243
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173

